COMMUNIQUÉS West-GlobeNewswire

Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
28/04/2026
Emergent’s Canton facility will manufacture drug substance and obtains exclusive distribution rights GAITHERSBURG, Md. and GENEVA, April 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today [...]
electroCore to Present at the Market Movers Investor Summit on May 5, 2026
28/04/2026
ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the Market Movers [...]
Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics
28/04/2026
Vienna, Austria, April 28, 2026 (GLOBE NEWSWIRE) -- Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing multiple cancer types Vienna, Austria, April 28, 2026 – Proxygen, a [...]
Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congress on Obesity
28/04/2026
Analyses of the higher dose of Wegovy ® (semaglutide 7.2 mg) and Wegovy ® pill (oral semaglutide 25 mg) show how fast and how much sustained weight loss people who responded early to treatment achieved Wegovy ® ( [...]
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
28/04/2026
SOMERSET, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, May 12 [...]
Leadership Team Expansion to Support the Need for Healthier Employees
28/04/2026
TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Employers of all sizes are confronting unprecedented economic and geopolitical pressures that are resulting in crisis levels of employee burnout and mental health challenges. [...]
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
28/04/2026
Oak Ridge, TN, April 28, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will exhibit its Blood Volume Analyzer (BVA ™ ) technology [...]
Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand
28/04/2026
Positioned to Meet Accelerating Travel Activity across New York City, The Hamptons, Nantucket and Martha’s Vineyard Scalable Short-Haul Luxury Aviation Platform Targeting Key Regional Travel Markets FORT MILL, S.C., [...]
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
28/04/2026
Using epigenomic mapping and regulatory RNA (regRNA) Capture-seq, CAMP4 has assembled what it believes to be the largest catalog of regRNAs ever compiled, uncovering thousands of previously undiscovered regRNAs in human [...]
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
28/04/2026
JENA, Germany, April 28, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system (the “Company”), today announced [...]
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
28/04/2026
HOLLISTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2026, before the market opens on May 12, 2026, and will [...]
Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
28/04/2026
Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments NEW YORK [...]
BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White
28/04/2026
- New national campaign encourages recognition of ATTR-CM, often mistaken for other heart conditions, where earlier diagnosis and treatment may help improve outcomes 1 PALO ALTO, Calif., April 28, 2026 (GLOBE NEWSWIRE [...]
Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress
28/04/2026
SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced nine presentations at the European Society of Cardiology Heart Failure 2026 Congress taking place [...]
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
28/04/2026
With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the trial remains on track [...]
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
28/04/2026
– ARCALYST ® (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth – – ARCALYST 2026 expected net product revenue increased to $930 - $945 million – – KPL-387 Phase 2 [...]
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
28/04/2026
Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancers HOUSTON, April 28, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus [...]
Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
28/04/2026
ATLANTA, April 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Barclays 30 th Annual Leveraged Finance Conference in [...]
Biomolecular Holdings Announces Issuance of Foundational Patents for Revolutionary Tetrahedral Antibody Technology
28/04/2026
BURLINGAME, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Biomolecular Holdings LLC, a privately-held biotechnology company advancing next-generation antibody architectures, today announced that the United States Patent [...]

Pages